Clinical Trial Update: The P10s-PADRE Basket Trial: Vaccination of Metastatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 basket trial of the P10s-PADRE vaccine for metastatic cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• P10s-PADRE vaccine

Snippet

Sponsor: University of Arkansas | Conditions: Neoplasms by Site, Metastatic Cancer | Phase 2 | Status: WITHDRAWN